Flush and find: sewage may reveal hidden superbug spread in elderly homes
NCT ID NCT07234331
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether testing wastewater from nursing homes can predict how many residents carry antibiotic-resistant bacteria. Researchers will collect stool or swab samples from 1,600 residents and compare them to bacteria levels in the facility's wastewater. The goal is to create a model that uses wastewater data to monitor resistance, reducing the need for individual testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Nursing home residents located in Loire-Atlantique and Maine-et-Loire, France
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Residents present on the day of sampling (D0 or D+1) in a facility selected during randomization, without criteria regarding length of stay in the facility, and whose health status on the day of the survey permits it; * Residents who, based on clinical criteria (including an MMSE greater than or equal to 20), are deemed by the nursing home team to be able to understand the issues of the study and to express an informed non-opposition; OR Residents who the nursing home team considers unable to express an informed non-objection but who have a legal representative, a trusted person, or a loved one capable of understanding the information and expressing an informed non-objection. Residents may be included regardless of the presence of infection, diarrheal stools, antibiotic use or any other treatment, or health status. Participants in this study may participate in other research projects concurrently. Exclusion Criteria: Health and medico-social facilities not considered nursing homes (e.g., FAM, MAS, etc.); * Residents whose health status is incompatible with performing the procedure on the day of the survey (e.g., end-of-life with comfort care); * Residents with a Mini Mental State Examination (MMSE) score of less than or equal to 20, or without an MMSE score but who, according to nursing home professionals, are unable to provide an informed non-objection and who do not have a legal representative, trusted person, or relative capable of receiving information and providing an informed non-objection; * Residents, regardless of their MMSE score, who refuse to have the sample taken on the day of the survey even if their legal repre
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Antimicrobial resistance are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU d'Angers
RECRUITINGAngers, 49100, France
-
CHU de Nantes
RECRUITINGNantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mass antibiotic dosing could save thousands of children in niger
- Rapid molecular tests could help doctors prescribe antibiotics more precisely
- Scientists track superbug genes in pneumonia patients
- Could a sleep hormone help fight superbugs?
- Eye rosacea study seeks safer antibiotic use
- Metaphor messages boost antibiotic smarts in parents